Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neurology

• Publication date

  2014-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00415-014-7344-5PMID 24752808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data

  2015cited by this paper
• Intra-hospital delays in stroke patients treated with rt-PA: impact of preadmission notification

  2013cited by this paper
• Telestroke Ambulances in Prehospital Stroke Management: Concept and Pilot Feasibility Study

  2012cited by this paper
• A population‐based study of thrombolysis for acute stroke in South Australia

  2011cited by this paper
• Stroke awareness decreases prehospital delay after acute ischemic stroke in korea

  2011cited by this paper
• A population‐based study of thrombolysis for acute stroke in South Australia

  2011cited by this paper
• Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 Years

  2011cited by this paper
• Trends in thrombolytic use for ischemic stroke in the United States.

  2010cited by this paper
• Thrombolysis for ischaemic stroke: impact of the extension of the time-window in daily practice

  2010cited by this paper
• Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry

  2010cited by this paper
• Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)

  2010cited by this paper
• Intravenous Thrombolysis for Acute Cerebral Ischaemia: Comparison of Outcomes between Patients Treated at Working versus Nonworking Hours

  2010cited by this paper
• Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need?

  2010cited by this paper
• The Belgian experience with intravenous thrombolysis for acute ischemic stroke.

  2010cited by this paper
• Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

  2010cited by this paper
• Facilities available in French hospitals treating acute stroke patients: comparison with 24 other European countries

  2009cited by this paper
• A Comprehensive Review of Prehospital and In-Hospital Delay Times in Acute Stroke Care

  2009cited by this paper
• Hospital Arrival Time and Intravenous t-PA Use in US Academic Medical Centers, 2001–2004

  2009cited by this paper
• A Citywide Prehospital Protocol Increases Access to Stroke Thrombolysis in Toronto

  2009cited by this paper
• Preface

  2009cited by this paper
• Telestroke: The Use of Telemedicine in Stroke Care

  2009cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.

  2008cited by this paper
• Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.

  2008cited by this paper
• Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.

  2007cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• Facilities Available in European Hospitals Treating Stroke Patients

  2007cited by this paper
• The Main Components of Stroke Unit Care: Results of a European Expert Survey

  2007cited by this paper
• Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002.

  2006cited by this paper
• Reasons why few patients with acute stroke receive tissue plasminogen activator.

  2006cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke

  2005cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

  2005cited by this paper
• Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

  2005cited by this paper
• Factors Influencing Early Admission in a French Stroke Unit

  2002cited by this paper
• Stroke Units from Scientific Evidence to Practice: The Experience of the Lille Stroke Unit

  2000cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.

  1997cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group.

  1997cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• So stroke units save lives

  1994cited by this paper
• Do stroke units save lives?

  1993cited by this paper

• Variations in Methodological Approaches to Measuring Health Inequalities and Inequities: A Scoping Review of Acute Stroke Pathways

  2025cites this paper
• The impact of a comprehensive national policy on improving acute stroke patient care in Lithuania

  2022cites this paper
• Trends of r-tPA (Recombinant Tissue-Type Plasminogen Activator) Treatment and Treatment-Influencing Factors in Acute Ischemic Stroke

  2020cites this paper
• Télémédecine et accident vasculaire cérébral : « Rôle de la télémédecine dans les accidents vasculaires cérébraux »

  2020cites this paper
• Acute telestroke in France: A systematic review.

  2020cites this paper
• Access to mechanical thrombectomy for cerebral ischaemia: A population-based study in the North-of-France.

  2019cites this paper
• Ischémie cérébrale : la fin de la fatalité ?

  2019cites this paper
• Health Care Organization for the Management of Stroke: The French Perspective.

  2018cites this paper
• The Use of Telehealth to Reduce Inequalities in Cardiovascular Outcomes in Australia and New Zealand: A Critical Review.

  2017cites this paper
• Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia

  2016cites this paper
• Restriction of therapy mainly explains lower thrombolysis rates in reduced stroke service levels

  2016cites this paper
• Comparison of Baseline Characteristics Between Patients With and Without OLAE

  2016cites this paper
• Prise en charge de l’infarctus cérébral aigu

  2016cites this paper
• Les patients à fort risque d’accident vasculaire cérébral sont-ils capables d’en reconnaitre les signes ? L’étude IPRADA : Information des Patients à Risque d’AVC, Détection et Action

  2015influential citation
• [Improvement of stroke management: The most important might still have to come].

  2015cites this paper